Previous studies have revealed significantly reduced expression levels of the MAPT gene and significantly increased expression levels of the APP gene in frontal cortex, hippocampus, and hypothalamus samples of human AD relative to the control [21], [22]. This evidence concerns the gene APP and Alzheimer disease.